Source:http://linkedlifedata.com/resource/pubmed/id/17568401
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-1-18
|
pubmed:abstractText |
This study was carried out to determine whether polymorphisms of organic anion-transporting polypeptide 1B1 (OATP1B1) have an effect on rosuvastatin pharmacokinetics in Koreans. Among 200 subjects genotyped for OATP1B1 c.388A>G, and c.521T>C, 30 subjects were selected for the rosuvastatin pharmacokinetic study. The area under the concentration-time curve for 0 to infinity (AUC(0-infinity)) of rosuvastatin for group 1 (*1a/*1a, *1a/*1b, *1b/*1b), group 2 (*1a/*15, *1b/*15), and group 3 (*15/*15) were 111+/-49.3, 126+/-45.2, and 191+/-31.0 ng h/ml, respectively, with significant differences among the three groups (P=0.0429) and between *15/*15 and the other groups (P=0.0181). The maximum plasma concentration (Cmax) also showed a significant difference between *15/*15 and the other groups (P=0.0181). There were no significant differences in rosuvastatin-lactone pharmacokinetics among the three groups. The pharmacokinetic exposure of rosuvastatin was higher in the OATP1B1*15/*15 subjects than the others, suggesting a potential association between the OATP1B1 genetic polymorphisms and altered rosuvastatin pharmacokinetics in Korean populations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Fluorobenzenes,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA...,
http://linkedlifedata.com/resource/pubmed/chemical/Lactones,
http://linkedlifedata.com/resource/pubmed/chemical/Organic Anion Transporters,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/SLCO1B1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides,
http://linkedlifedata.com/resource/pubmed/chemical/rosuvastatin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1532-6535
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
83
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
251-7
|
pubmed:meshHeading |
pubmed-meshheading:17568401-Administration, Oral,
pubmed-meshheading:17568401-Area Under Curve,
pubmed-meshheading:17568401-Asian Continental Ancestry Group,
pubmed-meshheading:17568401-Fluorobenzenes,
pubmed-meshheading:17568401-Gene Frequency,
pubmed-meshheading:17568401-Genotype,
pubmed-meshheading:17568401-Humans,
pubmed-meshheading:17568401-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:17568401-Korea,
pubmed-meshheading:17568401-Lactones,
pubmed-meshheading:17568401-Organic Anion Transporters,
pubmed-meshheading:17568401-Phenotype,
pubmed-meshheading:17568401-Polymorphism, Genetic,
pubmed-meshheading:17568401-Pyrimidines,
pubmed-meshheading:17568401-Sulfonamides
|
pubmed:year |
2008
|
pubmed:articleTitle |
Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.
|
pubmed:affiliation |
Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|